Prescriptions for Affordability
Positive Reforms to Improve Prescription Drug Competition, Value and Innovation
The cost of health care is rising faster than wages, expanding a dangerous gap between the care consumers need and the care they can afford. Currently, there is a focus on one subset of health care spending because it is the most accessed part of the health care system: prescription drugs. As policy makers look for solutions to lower health care costs, we believe it is important to offer reforms firmly rooted in competitive markets and incentives that promote value, innovation, transparency and appropriate access to treatment.
Despite spirited debate from all areas of the health care system and in Washington, we have yet to see a consensus-based approach that engages a wide range of affected stakeholders in a concerted effort to address drug costs and overall health care spending.
To this end, CAHC is working with our broad membership, including: benefit managers, drug manufacturers, insurers, patients, consumers and employers to create proactive, bipartisan policy solutions that will lower costs.
Our policy solutions focus on:
Increasing Competition: Bring more generics and brands to the market to drive down costs and increase choices.
Rewarding Value: Reform outdated laws that prevent rewards for better outcomes and lower costs.
Improving Data Infrastructure & Utilization: Create better infrastructure and streamline processes needed to bring value-based arrangements and higher value treatments to market.
Preserving What Works: Reject policies that undermine functioning markets, hamper innovation, or jeopardize safety or access.